China Nuclear Medicine/Radiopharmaceutic Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic market. It also provides a detailed overview of the market of different regions across North Iba Molecular Imaging, Central Iba Molecular Imaging, South Iba Molecular Imaging, East Iba Molecular Imaging, Northeast Iba Molecular Imaging, Southwest Iba Molecular Imaging, Northwest Iba Molecular Imaging. The report deep analyzes type and application in Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine/Radiopharmaceutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Mallinckrodt

    • Advanced Accelerator Applications

    • Bayer Healthcare

    • GE Healthcare

    • Cardinal Health

    • Europe

    • Dongcheng

    • Advanced Molecular-imaging Solution

    • Nordion

    • China

    • Eczacibasi-Monrol Nuclear Products

    • China

    • Lantheus Medical Imaging

    • Europe

    • China

    • Ciaeriar

    • Iba Molecular Imaging

    • Iba Molecular Imaging

    • Iba Molecular Imaging

    • Iba Molecular Imaging

    • Iba Molecular Imaging

    • Iba Molecular Imaging

    • China Isotope Radiation

    • China Isotope Radiation

    • China Isotope Radiation

    • China Isotope Radiation

    By Type:

    • Diagnostic

    • Therapeutic

    By End-User:

    • Oncology

    • Thyroid

    • Cardiology

    • Others

    By Region:

    • North Iba Molecular Imaging

    • Central Iba Molecular Imaging

    • South Iba Molecular Imaging

    • East Iba Molecular Imaging

    • Northeast Iba Molecular Imaging

    • Southwest Iba Molecular Imaging

    • Northwest Iba Molecular Imaging

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine/Radiopharmaceutic Market

    • 1.3 Market Segment by Type

    • 1.3.1 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Diagnostic from 2016 to 2027

    • 1.3.2 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Therapeutic from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Oncology from 2016 to 2027

    • 1.4.2 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Thyroid from 2016 to 2027

    • 1.4.3 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Cardiology from 2016 to 2027

    • 1.4.4 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Nuclear Medicine/Radiopharmaceutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine/Radiopharmaceutic by Major Types

    • 3.4.1 Market Size and Growth Rate of Diagnostic

    • 3.4.2 Market Size and Growth Rate of Therapeutic

    4 Segmentation of Nuclear Medicine/Radiopharmaceutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine/Radiopharmaceutic by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceutic in Oncology

    • 4.4.2 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceutic in Thyroid

    • 4.4.3 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceutic in Cardiology

    • 4.4.4 Market Size and Growth Rate of Nuclear Medicine/Radiopharmaceutic in Others

    5 Market Analysis by Regions

    • 5.1 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production Analysis by Regions

    • 5.2 Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on Iba Molecular Imaging Economy

    6 North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 6.1 North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 6.2 North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    7 Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 7.1 Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 7.2 Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    8 South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 8.1 South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 8.2 South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    9 East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 9.1 East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 9.2 East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    10 Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 10.1 Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 10.2 Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    11 Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 11.1 Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 11.2 Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    12 Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis

    • 12.1 Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major Types

    • 12.2 Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Mallinckrodt

      • 13.1.1 Mallinckrodt Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Advanced Accelerator Applications

      • 13.2.1 Advanced Accelerator Applications Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Bayer Healthcare

      • 13.3.1 Bayer Healthcare Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 GE Healthcare

      • 13.4.1 GE Healthcare Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Cardinal Health

      • 13.5.1 Cardinal Health Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Europe

      • 13.6.1 Europe Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Dongcheng

      • 13.7.1 Dongcheng Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Advanced Molecular-imaging Solution

      • 13.8.1 Advanced Molecular-imaging Solution Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Nordion

      • 13.9.1 Nordion Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 China

      • 13.10.1 China Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Eczacibasi-Monrol Nuclear Products

      • 13.11.1 Eczacibasi-Monrol Nuclear Products Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 China

      • 13.12.1 China Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Lantheus Medical Imaging

      • 13.13.1 Lantheus Medical Imaging Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Europe

      • 13.14.1 Europe Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    • 13.15 China

      • 13.15.1 China Company Profile and Recent Development

      • 13.15.2 Market Performance

      • 13.15.3 Product and Service Introduction

    • 13.16 Ciaeriar

      • 13.16.1 Ciaeriar Company Profile and Recent Development

      • 13.16.2 Market Performance

      • 13.16.3 Product and Service Introduction

    • 13.17 Iba Molecular Imaging

      • 13.17.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.17.2 Market Performance

      • 13.17.3 Product and Service Introduction

    • 13.18 Iba Molecular Imaging

      • 13.18.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.18.2 Market Performance

      • 13.18.3 Product and Service Introduction

    • 13.19 Iba Molecular Imaging

      • 13.19.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.19.2 Market Performance

      • 13.19.3 Product and Service Introduction

    • 13.20 Iba Molecular Imaging

      • 13.20.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.20.2 Market Performance

      • 13.20.3 Product and Service Introduction

    • 13.21 Iba Molecular Imaging

      • 13.21.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.21.2 Market Performance

      • 13.21.3 Product and Service Introduction

    • 13.22 Iba Molecular Imaging

      • 13.22.1 Iba Molecular Imaging Company Profile and Recent Development

      • 13.22.2 Market Performance

      • 13.22.3 Product and Service Introduction

    • 13.23 China Isotope Radiation

      • 13.23.1 China Isotope Radiation Company Profile and Recent Development

      • 13.23.2 Market Performance

      • 13.23.3 Product and Service Introduction

    • 13.24 China Isotope Radiation

      • 13.24.1 China Isotope Radiation Company Profile and Recent Development

      • 13.24.2 Market Performance

      • 13.24.3 Product and Service Introduction

    • 13.25 China Isotope Radiation

      • 13.25.1 China Isotope Radiation Company Profile and Recent Development

      • 13.25.2 Market Performance

      • 13.25.3 Product and Service Introduction

    • 13.26 China Isotope Radiation

      • 13.26.1 China Isotope Radiation Company Profile and Recent Development

      • 13.26.2 Market Performance

      • 13.26.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Diagnostic from 2016 to 2027

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Therapeutic from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Thyroid from 2016 to 2027

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Cardiology from 2016 to 2027

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine/Radiopharmaceutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of Iba Molecular Imaging

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Nuclear Medicine/Radiopharmaceutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine/Radiopharmaceutic by Different Types from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceutic by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostic

    • Figure Market Size and Growth Rate of Therapeutic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Nuclear Medicine/Radiopharmaceutic by Different End-Users from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine/Radiopharmaceutic by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Thyroid

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Others

    • Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production by Regions

    • Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production Share by Regions

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production Share by Regions in 2016

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production Share by Regions in 2021

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Production Share by Regions in 2027

    • Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Regions

    • Table Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Regions

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Regions in 2016

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Regions in 2021

    • Figure Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Regions in 2027

    • Table North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure North Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure Central Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure South Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure East Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure Northeast Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure Southwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by Types from 2016 to 2027

    • Table Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types from 2016 to 2027

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2016

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2021

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by Types in 2027

    • Table Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption by End-Users from 2016 to 2027

    • Table Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2016

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2021

    • Figure Northwest Iba Molecular Imaging Nuclear Medicine/Radiopharmaceutic Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of Bayer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare

    • Figure Revenue and Market Share Analysis of Bayer Healthcare

    • Table Product and Service Introduction of Bayer Healthcare

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Cardinal Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health

    • Figure Sales and Growth Rate Analysis of Cardinal Health

    • Figure Revenue and Market Share Analysis of Cardinal Health

    • Table Product and Service Introduction of Cardinal Health

    • Table Company Profile and Development Status of Europe

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Europe

    • Figure Sales and Growth Rate Analysis of Europe

    • Figure Revenue and Market Share Analysis of Europe

    • Table Product and Service Introduction of Europe

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Advanced Molecular-imaging Solution

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Molecular-imaging Solution

    • Figure Sales and Growth Rate Analysis of Advanced Molecular-imaging Solution

    • Figure Revenue and Market Share Analysis of Advanced Molecular-imaging Solution

    • Table Product and Service Introduction of Advanced Molecular-imaging Solution

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of China

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China

    • Figure Sales and Growth Rate Analysis of China

    • Figure Revenue and Market Share Analysis of China

    • Table Product and Service Introduction of China

    • Table Company Profile and Development Status of Eczacibasi-Monrol Nuclear Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eczacibasi-Monrol Nuclear Products

    • Figure Sales and Growth Rate Analysis of Eczacibasi-Monrol Nuclear Products

    • Figure Revenue and Market Share Analysis of Eczacibasi-Monrol Nuclear Products

    • Table Product and Service Introduction of Eczacibasi-Monrol Nuclear Products

    • Table Company Profile and Development Status of China

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China

    • Figure Sales and Growth Rate Analysis of China

    • Figure Revenue and Market Share Analysis of China

    • Table Product and Service Introduction of China

    • Table Company Profile and Development Status of Lantheus Medical Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging

    • Table Product and Service Introduction of Lantheus Medical Imaging

    • Table Company Profile and Development Status of Europe

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Europe

    • Figure Sales and Growth Rate Analysis of Europe

    • Figure Revenue and Market Share Analysis of Europe

    • Table Product and Service Introduction of Europe

    • Table Company Profile and Development Status of China

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China

    • Figure Sales and Growth Rate Analysis of China

    • Figure Revenue and Market Share Analysis of China

    • Table Product and Service Introduction of China

    • Table Company Profile and Development Status of Ciaeriar

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ciaeriar

    • Figure Sales and Growth Rate Analysis of Ciaeriar

    • Figure Revenue and Market Share Analysis of Ciaeriar

    • Table Product and Service Introduction of Ciaeriar

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of Iba Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Iba Molecular Imaging

    • Figure Sales and Growth Rate Analysis of Iba Molecular Imaging

    • Figure Revenue and Market Share Analysis of Iba Molecular Imaging

    • Table Product and Service Introduction of Iba Molecular Imaging

    • Table Company Profile and Development Status of China Isotope Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope Radiation

    • Figure Revenue and Market Share Analysis of China Isotope Radiation

    • Table Product and Service Introduction of China Isotope Radiation

    • Table Company Profile and Development Status of China Isotope Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope Radiation

    • Figure Revenue and Market Share Analysis of China Isotope Radiation

    • Table Product and Service Introduction of China Isotope Radiation

    • Table Company Profile and Development Status of China Isotope Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope Radiation

    • Figure Revenue and Market Share Analysis of China Isotope Radiation

    • Table Product and Service Introduction of China Isotope Radiation

    • Table Company Profile and Development Status of China Isotope Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope Radiation

    • Figure Revenue and Market Share Analysis of China Isotope Radiation

    • Table Product and Service Introduction of China Isotope Radiation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.